Asian expert recommendation on management of skin and mucosal effects of radiation, with or without the addition of cetuximab or chemotherapy, in treatment of head and neck squamous cell carcinoma

Asian expert recommendation on management of skin and mucosal effects of radiation, with or without the addition of cetuximab or chemotherapy, in treatment of head and neck squamous cell carcinoma

© 2016 Zhu et al. With increasing numbers of patients with unresectable locoregionally advanced (LA) head and neck squamous cell carcinoma (HNSCC) receiving cetuximab/radiotherapy (RT), several guidelines on the early detection and management of skin-related toxicities have been developed. Consideri...

Full description

Saved in:

Bibliographic Details
Main Authors:	Guopei Zhu, Jin Ching Lin, Sung Bae Kim, Jacques Bernier, Jai Prakash Agarwal, Jan B. Vermorken, Dang Huy Quoc Thinh, Hoi Ching Cheng, Hwan Jung Yun, Imjai Chitapanarux, Prasert Lertsanguansinchai, Vijay Anand Reddy, Xia He
Format:	Journal
Published:	2018
Subjects:	Biochemistry, Genetics and Molecular Biology Medicine
Online Access:	https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84955248709&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/55245
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	Chiang Mai University

Similar Items

Asian expert recommendation on management of skin and mucosal effects of radiation, with or without the addition of cetuximab or chemotherapy, in treatment of head and neck squamous cell carcinoma
by: Zhu G., et al.
Published: (2017)

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
by: Barbara Burtness, et al.
Published: (2020)

Taxotere, cisplatin, fluorouracil, and leucovorin (TPFL)as induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck.
by: Pimkhuan Kamnerdsupaphon, et al.
Published: (2018)

Taxotere, cisplatin, fluorouracil, and leucovorin (TPFL)as induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck.
by: Kamnerdsupaphon P., et al.
Published: (2014)

Taxotere, cisplatin, fluorouracil, and leucovorin (TPFL)as induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck
by: Kamnerdsupaphon P., et al.
Published: (2014)

Five-and ten-year survival of squamous cell carcinoma of the head and neck in northern Thailand: A multivariate analysis
by: Somvilai Chakrabandhu, et al.
Published: (2020)

Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048
by: Danny Rischin, et al.
Published: (2022)

Relief of radiation-induced oral mucositis in head and neck cancer
by: Panwadee Putwatana, et al.
Published: (2018)

Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study
by: Harrington K.J.
Published: (2023)

Role of oral flora in chemotherapy-induced oral mucositis in vivo
by: Gupta, N, et al.
Published: (2021)

Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048
by: Rischin D.
Published: (2023)

Pembrolizumab Alone or with Chemotherapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in KEYNOTE-048: Subgroup Analysis by Programmed Death Ligand-1 Combined Positive Score
by: Barbara Burtness, et al.
Published: (2022)

Pattern of gene expression in squamous cell carcinoma of head and neck
by: Chidchanok Leethanakul
Published: (2008)

Interesting genes in carcinogenesis of head and neck squamous cell carcinomas
by: Chidchanok Leethanakul
Published: (2015)

Expression of cdk6 in head and neck squamous cell carcinoma
by: Sopee Poomsawat, et al.
Published: (2018)

Induction chemotherapy with paclitaxel, ifosfamide, and cisplatin followed by concurrent chemoradiotherapy for unresectable locally advanced head and neck cancer
by: Chitapanarux I., et al.
Published: (2014)

Induction chemotherapy with paclitaxel, ifosfamide, and cisplatin followed by concurrent chemoradiotherapy for unresectable locally advanced head and neck cancer
by: I. Chitapanarux, et al.
Published: (2018)

Pembrolizumab Alone or with Chemotherapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in KEYNOTE-048: Subgroup Analysis by Programmed Death Ligand-1 Combined Positive Score
by: Burtness B.
Published: (2023)

Telomerase activity in oral leukoplakia and head and neck squamous cell carcinoma
by: Apiwat Mutirangura, et al.
Published: (2018)

Phase I study of expanded natural killer cells in combination with cetuximab for recurrent/metastatic nasopharyngeal carcinoma
by: Lim, Chwee Ming, et al.
Published: (2022)

Impact of oral mucositis on short-term clinical outcomes in paediatric and adolescent patients undergoing chemotherapy
by: Cheng, K.K.F., et al.
Published: (2016)

Lactobacillus reuteri DSM 17938 and ATCC PTA 5289 ameliorates chemotherapy-induced oral mucositis
by: Gupta, N., et al.
Published: (2021)

FOLFIRI chemotherapy for metastatic colorectal cancer patients
by: Pimkhuan Kamnerdsupaphon, et al.
Published: (2018)

Cetuximab conjugated vitamin E TPGS micelles for targeted delivery ofdocetaxel for treatment of triple negative breast cancers
by: Kutty, R.V., et al.
Published: (2014)

MALAT1 decreases the sensitivity of head and neck squamous cell carcinoma cells to radiation and cisplatin
by: Kitsada Kangboonruang, et al.
Published: (2020)

Transcriptomic analysis of peripheral blood mononuclear cells in head and neck squamous cell carcinoma patients
by: Fardeela Bin-Alee, et al.
Published: (2020)

The role of epidermal growth factor receptor in head and neck squamous cell carcinoma in Thai patients
by: D. Sa-Nguanraksa, et al.
Published: (2020)

Clinical recommendations for defining platinum unsuitable head and neck cancer patient populations on chemoradiotherapy: A literature review
by: Myung Ju Ahn, et al.
Published: (2018)

The mechanism of TGF-beta 1-induced-MMP-9 expression in head and neck squamous cell carcinoma
by: Sariya Nuchanardpanit
Published: (2011)

Plasma vascular endothelial growth factor dysregulation in defining aggressiveness of head and neck squamous cell carcinoma
by: Boonchu Kulapaditharom, et al.
Published: (2018)

Signaling pathways required for matrix metalloproteinase-9 induction by betacellulin in head-and-neck squamous carcinoma cells
by: Pornchai O-Charoenrat, et al.
Published: (2018)

More than a Bubble: Extracellular Vesicle microRNAs in Head and Neck Squamous Cell Carcinoma
by: Wittaya Panvongsa, et al.
Published: (2022)

More than a Bubble: Extracellular Vesicle microRNAs in Head and Neck Squamous Cell Carcinoma
by: Panvongsa W.
Published: (2023)

Expression of mucin 2 glycoproteins forming the mucosal barrier of the gut in Indonesian indigenous naked neck chickens and normal feathered chickens.
by: Ariyadi, Bambang, et al.
Published: (2016)

Changes in perfusion CT of advanced squamous cell carcinoma of the head and neck treated during the course of concomitant chemoradiotherapy
by: Šurlan-Popovi?, K.Š, et al.
Published: (2020)

Characteristics and impact of HPV-associated p16 expression on head and neck squamous cell carcinoma in Thai patients
by: Chuleeporn Jiarpinitnun, et al.
Published: (2020)

Localization and Molecular Size of Mucin2 Glycoproteins Forming the Gut Mucosal Barrier in the Indonesian Indigenous Naked Neck and Normal Feathered Chickens
by: Ariyadi, Bambang, et al.
Published: (2015)

Localization and Molecular Size of Mucin2 Glycoproteins Forming the Gut Mucosal Barrier in the Indonesian Indigenous Naked Neck and Normal Feathered Chickens
by: Ariyadi, Bambang, et al.
Published: (2015)

Randomized phase III trial of concurrent chemoradiotherapy vs accelerated hyperfractionation radiotherapy in locally advanced head and neck cancer
by: Imjai Chitapanarux, et al.
Published: (2018)

Randomized phase III trial of concurrent chemoradiotherapy vs accelerated hyperfractionation radiotherapy in locally advanced head and neck cancer
by: Imjai Chitapanarux, et al.
Published: (2018)